FDA recalling some heartburn, blood pressure medicines that may present a cancer risk

Data pix.

ST. LOUIS - The FDA  is recalling some heartburn and blood pressure medicines that may present a cancer risk.

Denton Pharma Inc. is recalling antacid medications containing what may be a carcinogenic ingredient called NDMA. NDMA is an impurity that is considered a possible carcinogen by the US Environmental Protection Agency.

The FDA says the ingredient is found in ranitidine tablets, Zantac and other heartburn medications. The recall is for unexpired products in two dosage amounts.

Consumers with ranitidine tablets should check the FDA website for dosage and lots and immediately stop  using and discard the products and consult with their physicians about treatment options.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.